Article

Targeting alternative pathways in HER2-positive breast cancer.

University of Pittsburgh, Cancer Institute, Division of Hematology-Oncology, Magee-Womens Hospital, Pittsburgh, Pennsylvania, USA.
Oncology (Williston Park, N.Y.) (Impact Factor: 2.98). 04/2010; 24(5):415-6.
Source: PubMed
0 Followers
 · 
46 Views